Photocure: New meta-analysis shows that BLC with Hexvix®/Cysview® significantly reduces rate of progression in bladder cancer
02 août 2016 02h00 HE
|
Photocure ASA
Oslo, Norway, August 2, 2016 -- Photocure ASA announced today a new systematic review and meta-analysis on the impact of Blue Light Cystoscopy (BLC) with Hexvix® (Hexaminolevulinate) - versus White...
Photocure ASA: Save the date - Hexvix/Cysview update and second quarter 2016 results
06 juil. 2016 02h05 HE
|
Photocure ASA
Oslo, Norway, 6 July 2016: Photocure ASA will present its second quarter report on Tuesday 23 August 2016 at Hotel Continental, Norway, and is proud to announce Dr. Sia Daneshmand as keynote...
Photocure announces resignation of Chief Operating Officer
26 mai 2016 10h45 HE
|
Photocure ASA
Oslo, Norway, 26 May 2016: Photocure ASA announces today that its Chief Operating Officer, Kathleen Deardorff, has resigned effective 1 June 2016 to pursue other career opportunities. Ms Deardorff...
Photocure ASA: Share capital increase registered
26 mai 2016 07h31 HE
|
Photocure ASA
Reference is made to the announcement on 23 May 2016 in respect of a capital increase of 34 134 new shares following exercise of employee share options in the company. The share capital increase has...
Photocure ASA: Resolved share capital increase in connection with exercise of options
23 mai 2016 02h00 HE
|
Photocure ASA
The board of directors of Photocure ASA has resolved a share capital increase as a consequence of employees exercising vested options granted under the company's employee incentive scheme. Upon...
Photocure ASA: Results for first quarter 2016
10 mai 2016 01h30 HE
|
Photocure ASA
Oslo, Norway, 10 May 2016: Photocure (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, announces its results for the first quarter 2016. ...
Photocure ASA: Positive clinical data on BLC with Cysview®/Hexvix® presented at AUA
09 mai 2016 02h23 HE
|
Photocure ASA
Oslo, Norway, May 9, 2016 -- Photocure ASA announced today new data from a prospective multicenter ongoing registry study that shows Blue Light Cystoscopy (BLC) with Cysview® increases detection...
Photocure ASA: Presentation of the first quarter 2016 results
03 mai 2016 06h41 HE
|
Photocure ASA
Photocure will present its first quarter report on Tuesday 10 May 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be...
Photocure ASA: Enhanced cystoscopy including Blue Light Cystoscopy with Cysview®/Hexvix® is recommended in the New AUA/SUO Bladder Cancer Guideline
02 mai 2016 02h00 HE
|
Photocure ASA
Oslo, Norway, May 2, 2016: Photocure ASA announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016...
Photocure ASA: Minutes from Annual General Meeting
28 avr. 2016 14h00 HE
|
Photocure ASA
Oslo, Norway, 28 April, 2016. The Annual General Meeting in Photocure ASA took place on 28 April, 2016. A new Board of Directors was elected and consists of the following members until next...